Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the STD Diagnostics Market Size Changed, over the years?

Over the past few years, there has been robust growth in the size of the STD diagnostics market. The market is expected to expand from $9.93 billion in 2024 to $10.86 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The historical growth can be ascribed to factors such as trends in epidemiology, advancements in healthcare infrastructure, pharmaceutical breakthroughs, sexual education initiatives, and demographic transitions.

How Much Will the STD Diagnostics Market Be Worth in 2029?

In the forthcoming years, the STD diagnostics market is projected to experience robust growth, expanding to $16.21 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 10.5%. The surge during the forecast period can be linked to trends in personalized medicine, augmented accessibility to healthcare, public health strategies, telemedicine, and digital health, as well as an increase in STD occurrences. Key market trends anticipated during this period encompass advancements in point-of-care testing (POCT), the advent of home testing kits, multiplex testing, targeted marketing initiatives and outreach, the introduction of pre-exposure prophylaxis (prep) programs, among rising incidence rates.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Which is the Largest Company in the STD Diagnostics Market?

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

What Are the Main Market Drivers in the STD Diagnostics Industry?

The escalating incidents of sexually transmitted diseases (STDs) are the driving force behind the STD diagnostics market. STDs are communicable illnesses transferred through sexual relations from an infected individual to a healthy person. STD diagnostics offer proficient evaluation and testing for these infections. The World Health Organization (WHO), a global United Nations body aiming to enhance universal public health, revealed in 2022 that more than 1 million sexually-transmitted infections occur daily worldwide. Furthermore, about 374 million new cases annually are diagnosed with one out of four STDs, including chlamydia, gonorrhea, syphilis, and trichomoniasis. Consequently, the increasing occurrence of STDs is fueling the STD diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8507&type=smp

How Is the STD Diagnostics Market Segments Structured?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

What Strategic Trends Are Transforming the STD Diagnostics Market?

The proliferation of STD diagnostics signifies a crucial trend in the STD diagnostic market. Major corporations are enhancing their testing amenities and strategies for a more efficient and expedited diagnosis of sexually transmitted diseases. For example, BD (Becton, Dickinson, and Company), a medical technology firm based in the USA, unveiled a wholly automated, high-throughput infectious disease molecular diagnostics platform, coined as BD CORTM MX/PX System in May 2022. This platform consolidates and mechanizes the molecular laboratory procedure, spanning from sample processing to the delivery of diagnostic test results. The inaugural test accessible on this new platform is the BD CTGCTV2 molecular assay, a standalone test that can detect the top three non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the STD Diagnostics Market?

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

This Report Delivers Insight On:

1. How big is the std diagnostics market, and how is it changing globally?

2. Who are the major companies in the std diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the std diagnostics market right now?

4. Which products or customer segments are growing the most in the std diagnostics market?

5. What factors are helping or slowing down the growth of the std diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model